MedTrace Logo

A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms

NCT02413437 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2088

Last updated 2017-05-08

No results posted yet for this study

Summary

The purpose of this study is to estimate the clinical value of contrast-enhanced ultrasound in percutaneous biopsy for liver occupied lesion.

Conditions

  • Liver Neoplasms

Interventions

OTHER

CEUS guided biopsy

Biopsy was operated under contrast-enhanced ultrasound-guided.

OTHER

US guided biopsy

Biopsy was operated under conventional ultrasound-guided.

DEVICE

Ultrasound

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    lead OTHER

Principal Investigators

  • Kun Yan, master · Peking University Cancer Hospital & Institute

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02413437 on ClinicalTrials.gov